CVE-2022-45611

CRITICAL

9.8

Beschreibung

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

CVE Details

CVSS v3.1 Bewertung9.8

SchweregradCRITICAL

CVSS VektorCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

AngriffsvektorNETWORK

KomplexitatLOW

Erforderliche PrivilegienNONE

BenutzerinteraktionNONE

Veroffentlicht8/22/2023

Zuletzt geandert11/21/2024

Quellenvd

Honeypot-Sichtungen0

Betroffene Produkte

fresenius-kabi:pharmahelpfresenius-kabi:pharmahelp_firmware

Schwachen (CWE)

CWE-522

Referenzen

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

IOC Korrelationen

Keine Korrelationen erfasst

This product uses data from the NVD API but is not endorsed or certified by the NVD.